SCHEMBL19082127

SCHEMBL19082127

c1ccc2cc(-c3c4ccccc4c(-c4ccc5c(c4)sc4ccc6c(sc7ccc8ccccc8c76)c45)c4ccccc34)ccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 2/20 0.36
NQO1 P15559 1/20 0.36
CYP1A1 P04798 3/20 0.35
CYP1B1 Q16678 3/20 0.35
CYP1A2 P05177 2/20 0.33
PTPN1 P18031 1/20 0.33
PDE9A O76083 1/20 0.32
ALOX5 P09917 2/20 0.32
GSTP1 P09211 1/20 0.32
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
MAPK9 P45984 1/20 0.32
MAPK14 Q16539 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
CYP3A4 P08684 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
CASP1 P29466 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17944156 0.96 NQO2 (0.38) NQO2NQO1CYP1A1CYP1B1CYP1A2
SCHEMBL19082302 0.95 HSD17B1 (0.36) NQO2NQO1CYP1A1CYP1B1CYP1A2
SCHEMBL19082160 0.95 HSD17B1 (0.36) NQO2NQO1CYP1A1CYP1B1CYP1A2
SCHEMBL19082128 0.92 NQO2 (0.35) NQO2NQO1CYP1A1CYP1B1CYP1A2
SCHEMBL19082130 0.92 CYP1A1 (0.39) NQO2NQO1CYP1A1CYP1B1CYP1A2
SCHEMBL10122721 0.92 NQO2 (0.36) NQO2NQO1CYP1A1CYP1B1CYP1A2
SCHEMBL19082124 0.92 NQO2 (0.36) NQO2NQO1CYP1A1CYP1B1CYP1A2
SCHEMBL17943979 0.92 ESR1 (0.38) NQO2NQO1CYP1A1CYP1B1PDE9A
SCHEMBL10122714 0.92 NQO2 (0.36) NQO2NQO1CYP1A1CYP1B1CYP1A2
SCHEMBL13507613 0.92 GSTP1 (0.35) NQO2NQO1CYP1A1CYP1B1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 NQO2 2592/4885NQO1 576/4885CYP1A1 184/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 NQO2 2592/4885NQO1 576/4885CYP1A1 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.